Skip to main content

Published locations for HER2-positive early BC: Trastuzumab+pertuzumab+chemotherapy remains the standard care

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-positive early BC: Trastuzumab+pertuzumab+chemotherapy remains the standard care

User login

  • Reset your password
  • /content/her2-positive-early-bc-trastuzumabpertuzumabchemotherapy-remains-standard-care
  • /hematology-oncology/article/250859/breast-cancer/her2-positive-early-bc
  • /breast-cancer-icymi/article/250859/breast-cancer/her2-positive-early-bc